Vol 13, No 3 (March 27, 2024): Translational Pediatrics

Impact of the COVID-19 pandemic on the demographic and disease burden of pediatric malignant solid tumors in China: a single-center, cross-sectional study

Analysis of clinical features of heart failure in children with cardiomyopathy and improved ejection fraction

Characterization of brain development with neuroimaging in a female mouse model of chemotherapy treatment of acute lymphoblastic leukemia

The application of machine learning based on computed tomography images in the identification of renal tumors in children

Ulnar osteotomy between the proximal 1/3 and 1/5 provides a stable radiocapitellar joint in chronic Monteggia fracture

Polymorphic markers of several immune regulatory genes modulate the susceptibility for eczema and related phenotypes in children

Comparison of diagnostic criteria for sepsis-associated acute kidney injury in the pediatric intensive care unit: a retrospective cohort study

Withdrawal and withholding of life sustaining treatment (WWLST): an under recognised factor in the morbidity or mortality of periviable infants?—a narrative review

Eosinophilic esophagitis: absolute eosinophilic count, peak eosinophilic count, and potential biomarkers of eosinophilic degranulation products—an in-depth systematic review

A rare inherited homozygous missense variant in PLA2G6 influences susceptibility to infantile neuroaxonal dystrophy: a case report

Pediatric Ménière’s disease with disassociated cochlear and vestibular symptoms: a case report

Treatment of metastatic TFE3 microphthalmia transcription factor translocation renal cell carcinoma: a case report

Can video laryngoscopy and supplemental oxygen redefine pediatric, infant and neonatal tracheal intubation standards?

Advances in the treatment of BRAF-mutant low-grade glioma with MAPK inhibitors

Hypertension monitoring on cardiac health outcomes

Will nirsevimab be the holy grail for prevention of respiratory syncytial virus lower respiratory tract infections in infants?

Blinatumomab improves outcomes for pediatric patients with low-risk B-cell acute lymphoblastic leukemia in first marrow relapse